Effect of Upadacitinib on Disease Activity, Pain, Fatigue, Function, Health-Related Quality of Life and Work Productivity for Biologic Refractory Ankylosing Spondylitis

INTRODUCTION: Patients with ankylosing spondylitis (AS) have significant unmet treatment needs, despite advancements in biologic therapies. This study evaluated the impact of upadacitinib on clinically meaningful improvement in patient-reported outcomes (PROs) assessing disease activity, pain, fatig...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Compán, Victoria, Baraliakos, Xenofon, Magrey, Marina, Östör, Andrew, Saffore, Christopher D., Mittal, Manish, Song, In-Ho, Ganz, Fabiana, Stigler, Jayne, Deodhar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948782/
https://www.ncbi.nlm.nih.gov/pubmed/36820984
http://dx.doi.org/10.1007/s40744-023-00536-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948782/
https://www.ncbi.nlm.nih.gov/pubmed/36820984
http://dx.doi.org/10.1007/s40744-023-00536-2

Ejemplares similares